Risedronaat Sandoz 35 mg film-coat. tabl.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Sodium Risedronate 35 mg - Eq. Risedronic Acid 32,5 mg
Available from:
Sandoz SA-NV
ATC code:
M05BA07
Pharmaceutical form:
Film-coated tablet
Administration route:
Oral use
Therapeutic area:
Risedronic Acid
Product summary:
CTI Extended: 376616-06; 376616-02; 376616-03; 376616-04; 376616-08; 376616-07; 376616-01; 376616-05
Authorization status:
Commercialised: No
Authorization date:
2010-08-30
